Last $106.47 USD
Change Today +1.03 / 0.98%
Volume 409.7K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for pacira pharmaceuticals inc (PCRX)

Year over year, Pacira Pharmaceuticals, Inc. has seen their bottom line shrink from a loss of $52.3M USD to an even larger loss of $63.9M USD despite an increase in revenues from $39.1M USD to $85.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
Cost of Goods Sold30.931.638.976.3
GROSS PROFIT-16.3-15.90.29.2
Selling General & Admin Expenses, Total6.420.246.362.5
Interest Expense-4.9-4.8-2.1-7.9
Interest and Investment Income0.10.30.30.3
EBT, INCLUDING UNUSUAL ITEMS-27.1-43.3-52.3-64.4
Income Tax Expense-------0.4
Earnings from Continuing Operations-27.1-43.3-52.3-63.9
NET INCOME-27.1-43.3-52.3-63.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-27.1-43.3-52.3-63.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-27.1-43.3-52.3-63.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $106.47 USD +1.03

PCRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $43.00 USD +0.74
Cumberland Pharmaceuticals Inc $5.98 USD +0.02
Durect Corp $0.92 USD -0.0198
Halyard Health Inc $46.00 USD -0.31
Teleflex Inc $111.75 USD -1.08
View Industry Companies
 

Industry Analysis

PCRX

Industry Average

Valuation PCRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.4x
Price/Book 24.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.